NCAM polysialylation plays a critical role in neuronal development and regeneration. Polysialylation of the neural cell adhesion molecule (NCAM) is catalyzed by two polysialyltransferases, ST8Sia II (STX) and ST8Sia IV (PST), which contain sialylmotifs L and S conserved in all members of the sialyltransferases. The members of the ST8Sia gene family, including ST8Sia II and ST8Sia IV are unique in having three cysteines in sialylmotif L, one cysteine in sialylmotif S, and one cysteine at the COOH terminus. However, structural information, including how disulfide bonds are formed, has not been determined for any of the sialyltransferases. To obtain insight into the structure/function of ST8Sia IV, we expressed human ST8Sia IV in insect cells, Trichoplusia ni, and found that the enzyme produced in the insect cells catalyzes NCAM polysialylation, although it cannot polysialylate itself ("autopolysialylation"). We also found that ST8Sia IV does not form a dimer through disulfide bonds. By using the same enzyme preparation and performing mass spectrometric analysis, we found that the first cysteine in sialylmotif L and the cysteine in sialylmotif S form a disulfide bridge, whereas the second cysteine in sialylmotif L and the cysteine at the COOH terminus form a second disulfide bridge. Site-directed mutagenesis demonstrated that mutation at cysteine residues involved in the disulfide bridges completely inactivated the enzyme. Moreover, changes in the position of the COOH-terminal cysteine abolished its activity. By contrast, the addition of green fluorescence protein at the COOH terminus of ST8Sia IV did not render the enzyme inactive. These results combined indicate that the sterical structure formed by intramolecular disulfide bonds, which bring the sialylmotifs and the COOH terminus within close proximity, is critical for the catalytic activity of ST8Sia IV.
In the development of the nervous system, various cell-typespecific carbohydrates presented by glycoproteins, proteoglycans, and glycolipids function in signal transduction, neurite outgrowth, neuronal plasticity, and synapse formation (1, 2) . Among these carbohydrates, polysialic acid is a linear homopolymer of ␣2,8-linked sialic acid, primarily attached to the neural cell adhesion molecule (NCAM) 1 (3) (4) (5) . Polysialylated NCAM is abundant in embryonic brain, whereas most NCAM in adult brain does not contain polysialic acid. However, polysialylated NCAM is continuously present in hippocampus and the olfactory bulb, where neuronal regeneration persists in the adult (6) . Studies using endoneuraminidase showed that cell migration and synaptic plasticity are dependent on the presence of polysialic acid (7, 8) . In contrast with vertebrate NCAM, NCAM homologues in Aplysia and Drosophila, apCAM and FasII, respectively, are not polysialylated. In these species, their activity in neuronal regeneration and axon guidance is modulated by removal of the protein from the cell surface by endocytosis (9) or expression of an anti-adhesive protein (10) . These results indicate that polysialic acid evolved in vertebrates and plays critical roles in formation and remodeling of the nervous system as a common and unique regulator of the adhesive property of NCAM in vertebrates.
Polysialic acid is also detected in neuroblastoma (11) , Wilms' tumor (12) , and lung carcinomas (13, 14) . In both small cell and non-small cell lung carcinomas, the expression of polysialic acid is associated with tumor progression, in particular with tumor metastasis (13, 14) . In addition, capsules of certain pathogenic bacteria that cause meningitis bear polysialic acid (15) . These combined results suggest that polysialic acid facilitates cell migration and allows pathogens to avoid attack by the immune system in vivo. To develop therapeutic agents for the treatment of these diseases and determine the roles of polysialic acid in neural development, it is important to understand the mechanisms of polysialic acid synthesis.
To date, two polysialyltransferases, ST8Sia IV (PST) and ST8Sia II (STX), have been cloned and shown to synthesize polysialic acid on NCAM (16 -20) . These enzymes catalyze transfer of multiple ␣2,8-linked sialic acid residues to an acceptor containing a NeuNAc␣233Gal␤134GlcNAc3 R structure without participation of other enzymes (21) (22) (23) (24) , and the presence of polysialic acid is always associated with expression of ST8Sia II and/or IV (25, 26) . The amino acid sequences of these mammalian polysialyltransferases are not related to bacterial polysialic acid synthase (27) . Recent studies demonstrate that inactivation of ST8Sia IV in mice through homologous recombination leads to impaired long term potentiation and long term depression in Schaffer collateral-CA1 synapses of the adult hippocampus (28) . Loss of polysialic acid in the above mutant mice was incomplete, because ST8Sia II compensates for the loss of ST8Sia IV. These results suggest that ST8Sia IV and ST8Sia II are the key enzymes that control the expression of polysialic acid in vivo.
Polysialyltransferases belong to the vertebrate sialyltransferase gene family that includes ␣2,3-, ␣2,6-, and ␣2,8-sialyltransferases. Sialyltransferases have a type II membrane protein topology as do almost all Golgi-associated glycosyltransferases cloned so far. As generally seen for these enzymes, a short cytoplasmic segment of ST8Sia II and IV is connected to a transmembrane domain followed by a large intraluminal domain consisting of a stem region and catalytic domain. Analysis of the amino acid sequences of various sialyltransferases shows two weak but discernible homologous regions in their catalytic domains, called sialylmotifs L and S (29) . It has been demonstrated by analysis of ST6Gal I that sialylmotif L is involved in the binding to the donor substrate, CMP-NeuNAc, whereas sialylmotif S participates in the binding to both donor and acceptor substrates (30, 31) . The members of ␣2,8-sialyltransferases (ST8Sia) are characteristic in having one conserved cysteine at the COOH-terminal end, three cysteine residues in the sialylmotif L, and one in the sialylmotif S (Fig.  1) . On the other hand, all of the other sialyltransferases contain only one conserved cysteine residue in each sialylmotifs L and S. Except for ST6Gal I (32), none of the other sialyltransferases contains a cysteine at the COOH terminus. Disulfide bond structures have not been determined for any members of sialyltransferases, and it is not known how sialylmotifs L and S work together.
In the present study, we first expressed ST8Sia IV in insect cells using a Baculovirus system. We found that ST8Sia IV produced in insect cells or mammalian cells exists as a monomer and adds polysialic acid to NCAM, although the enzyme preparation from the insect cells cannot polysialylate itself ("autopolysialylation" (33, 34) ). We then determined by mass spectrometric analysis that disulfide bonds are intramolecularly formed between the COOH terminus and sialylmotif L and between sialylmotifs L and S. Moreover, site-directed mutagenesis experiments demonstrated the absolute requirement of these disulfide bridges and the position of the cysteine at the COOH terminus. These results indicate that sialylmotifs L and S and the COOH-terminal region are close to each other, and such a unique sterical structure is important for the polysialylation activity of ST8Sia IV.
EXPERIMENTAL PROCEDURES
Plasmids-Isolation of pcDNAI harboring ST8Sia IV cDNA, pcDNAI-ST8Sia IV, and a soluble form of ST8Sia IV fused to a signal peptide and the IgG binding domain of protein A, pcDNAI-A⅐ST8Sia IV, was described previously (18, 21) . pcDNAI-ST8Sia II and pcDNAI-A⅐ST8Sia II were cloned as described previously (35) . pIGNCAM⅐IgG(VASE,MSD) encoding a soluble NCAM-140 fused with a hinge and constant regions of IgG was kindly provided by Dr. David Simmons at Oxford University (36) . The vector, originally designated as pIG-NCAM, was found to contain both VASE and MSD sequences. Because such an NCAM(VASE,MSD) is unusual, a 2198-bp DNA sequence containing both VASE and MSD sequences was excised with HindIII and KpnI from pIG-NCAM(VASE,MSD) and was replaced with the corresponding HindIII/KpnI fragment (2050 bp) of NCAM-140 (17), resulting in pIG-NCAM. The obtained cDNA sequence was confirmed by nucleotide sequencing.
To construct cDNA encoding ST8Sia IV fused with FLAGF epitope or GFP protein, cDNA fragment encoding ST8Sia IV was amplified by PCR using T7 primer and 3Ј-primer (5Ј-CTGGTACCTGCTTTACA-CACTTTCC-3Ј; the KpnI site is underlined, and the rest of the sequence encodes nucleotides 1076 -1060 of ST8Sia IV). The PCR product was digested with HindIII and KpnI and subcloned into the same sites of pFLAG-CMV-5b (Sigma) or pcDNA3.1-EGFP, resulting in pFLAGST8Sia IV or pcDNA3.1-ST8Sia IV⅐EGFP. Similarly, ST8Sia II cDNA fragment was amplified by PCR using T7 primer and 3Ј-primer (5Ј-TGGTACCGTGGCCCCATCGCACTGGCC-3Ј; the KpnI site is underlined, and the rest of the sequence encodes 1124 -1105), and pFLAGST8Sia II and pcDNA3.1-ST8Sia II⅐EGFP were obtained. pcDNA3.1-EGFP was constructed from pEGFP-N1 (CLONTECH) by excising cDNA fragment with EcoRI/NotI digestion and cloned into the same sites of pcDNA3.1 (Invitrogen).
The cDNAs for the full-length enzymes fused with the FLAG epitope were expressed in HeLa cells, and all the lysates were dissolved in the sample buffer with or without 2-mercaptoethanol. FLAG-tagged enzymes were detected by Western blot analysis using anti-FLAG antibody (Sigma Chemical Co.) and the ECL Plus kit (Amersham Pharmacia Biotech).
Construction of Soluble ST8Sia IV and ST8Sia II Tagged with 6ϫHis Peptide-A vector for soluble form-containing 6ϫHis peptide was first constructed as follows. A KpnI-HindIII fragment encoding a signal peptide from pcDNAI⅐A vector (21) and a HindIII-BamHI fragment of pcDNA3.1-HisB (Invitrogen) encoding for 6ϫHis peptide were subcloned into pcDNA3.1-Hygro after digestion with KpnI and BamHI, resulting in pcDNA3.1-HSH (Hygro-Signal-6ϫHis). A BamHI-XbaI fragment of pcDNAI-A⅐ST8Sia IV (nucleotides 118 -1080) was subcloned into the same sites of pcDNA3.1-HSH, resulting in pcDNA3.1-His⅐ST8Sia IV, which harbors the coding region of a signal peptide, His tag, and catalytic domain of ST8Sia IV. Similarly, a PCRamplified BglII-XhoI fragment of ST8Sia II (nucleotides 95-1125) (24) was placed into pcDNA3.1-HSH digested with BamHI and XhoI. His⅐ST8Sia IV and His⅐ST8Sia II released from transfected mammalian and insect cells were detected by Western blot analysis using antiXpress antibody (Invitrogen) and an ECL Plus kit.
Soluble ST8Sia IV Expression Using a Baculovirus System-A BamHI-XbaI fragment of pcDNAI-A⅐ST8Sia IV (21) was subcloned into the same sites of pcDNA3.1-HisB. Using this construct as a template, cDNA encoding 6ϫHis peptide and the same portion of ST8Sia IV as A⅐ST8Sia IV was amplified by PCR and subcloned into BamHI and XbaI sites of the pAcGP67A vector (PharMingen), which contains a gp67 secretion signal peptide driven by the Baculovirus polyhedrin promoter, resulting in pAcGP67A-His⅐ST8Sia IV. This transfer vector was used to obtain recombinant Baculovirus. High-Five insect cells, Trichoplusia ni (Invitrogen), were infected with the recombinant Baculovirus, and culture medium was collected 3 days after infection. His-tagged ST8Sia IV fusion protein, His⅐ST8Sia IV (BV), secreted from the insect cells was purified using ProBond Ni-beads (Invitrogen). His⅐ST8Sia IV (BV) eluted from Ni-beads was used as an enzyme source. For protein chemical analysis, the enzyme was concentrated by Microcon 30 (Millipore) and washed with 20 mM Tris-HCl, pH 7.4, three times. The recovered protein at a concentration of 0.5 g/l was used for disulfide mapping analysis as follows.
Liquid Chromatography/Electrospray Ionization-Tandem Mass Spectrometry (LC/ESI-MS/MS) Analyses-A sample of the concentrated ST8Sia IV (ϳ15 g in 30 l) was treated with a 20 times molar excess of PEO-maleimide-activated biotin and immediately denatured with 8 M urea. The sample was incubated for 60 min in the dark at room temperature (total volume, 45 l). The concentration of urea in the sample was reduced to 2 M by addition of water. Trypsin or chymotrypsin (1/10, w/w ratio of the protease/protein) was then added, and the mixture (180 l) was incubated overnight at 37°C. A portion of the proteolytic digest was treated with N-glycanase overnight at 37°C. N-glycanase was dissolved at a concentration of 200 units/ml in 100 mM sodium phosphate containing 25 mM EDTA, pH 7.2, and added to the proteolytic digest to a final concentration of 20 units/ml. The digests were fractionated using a capillary C18 column (150 ϫ 0.18 mm; Nucleosil, 5-m particle size) and analyzed on a Finnigan LCQ ion trap mass spectrometer with a modified electrospray ionization (ESI) source (37) . The LC/MS analysis was conducted using a Hewlett-Packard 1050 high pressure liquid chromatography system coupled to the LCQ. The mobile phase was split before the injector by a Tee-connector, and a flow rate of 2 l/min was established through the capillary C18 column. The sample was eluted by three-step linear gradient from 95% of the solution A (0.5% formic acid in water) and 5% of the solution B (0.5% formic acid in acetonitrile) in the first 10 min, 10 -35% of the solution B in the next 40 min, and 35-40% of the solution B in the last 5 min. The LC/ESI-MS/MS analysis was performed using an automated data acquisition procedure, in which a cyclic series of three different scan modes was performed (35, 36) . Data acquisition was conducted using the full scan mode (m/z 300 -2000) to obtain the most intense peak (signal Ͼ 1.5 ϫ 10 5 counts) as the precursor ion, followed by a high resolution zoom scan mode to determine the charge state of the precursor ion and an MS/MS scan mode (with a relative collision energy of 38%) to determine the structural fragment ions of the precursor ion. The resulting MS/MS spectra were then searched against a protein data base (Owl) by Sequest to confirm the sequence of tryptic or chymotryptic peptides. The details of the LC/ESI-MS/MS procedure were described elsewhere (38) .
Deletion and Mutation of ST8Sia IV cDNA-Five Cys residues in ST8Sia IV were mutated to Ala by the PCR. C142A was introduced by ligating two PCR-amplified fragments. 5Ј-and 3Ј-primers for the first PCR are T7 primer and 5Ј-CGGCCGGCGGTCTTAAACCTGCGAT-TCTTC-3Ј. For the second PCR, 5Ј-CTTTGCGCAGTTGTTGGAAAT-TCTGGCAT-3Ј (5Ј-primer) and a downstream primer containing the stop codon and XbaI site were used for the second PCR. After digestion with NaeI and FspI, these two PCR products are ligated at GCCGCA sequence containing Ala 142 instead of Cys 142 (the codon for Ala 142 is singly underlined). Other mutations were made as follows: C156A (GAGGCA, generated by digestion with Ecl136II (GAGCTC) and FspI (TGCGCA)), C169A (AGGGCA, generated by digestion with StuI (AG-GCCT) and FspI (TGCGCA)), C292A (TTTGCA, generated by digestion with DraI (TTTAAA) and FspI (TGCGCA)); single underlines denote Ala codons. C356A mutant was made as described below.
From the ST8Sia IV COOH terminus, two to four amino acids were removed by PCR using the 5Ј-primer 5Ј-GGGTCTCCCTCAGTTGTA-CAAAGAGCATTT-3Ј (the underlined sequence corresponds to nucleotides 577-597) and the 3Ј-primer containing a deletion followed by a stop codon and an XbaI site. The amplified fragment digested with PmlI and XbaI replaced wild-type sequences of pcDNAI-ST8Sia IV. (23) .
In Vitro Polysialyltransferase Assays-COS-1 cells were transfected with cDNAs encoding wild-type or mutant forms of soluble enzymes. Forty-eight h after transfection, the culture medium was changed to serum-free medium (Life Technologies), and the cells were incubated for another 24 h. Soluble enzymes were collected from the spent media using human IgG-Sepharose (Amersham Pharmacia Biotech). The quantity of each enzyme bound to the beads was measured by Western blot analysis using peroxidase-conjugated rabbit immunoglobulins (Cappel) and an ECL Plus kit as described previously (23) . An equivalent amount of each mutant enzyme adsorbed to beads was used for in vitro sialyltransferase assays in 50 mM sodium cacodylate buffer, pH 6.0, containing 2.5 mM MgCl 2 , 2.5 mM MnCl 2 , 1 mM CaCl 2 , 0.5% Triton CF-54, 2.4 nmol (0.7 Ci) of CMP-[
14 C]NeuNAc, and 10 pmol of NCAM⅐IgG. After incubation, NCAM⅐IgG in the supernatant was obtained by brief centrifugation and subjected to SDSpolyacrylamide gel electrophoresis followed by fluorography as described previously (21, 23) . For the assay of autopolysialylation, the incubation mixture omitted NCAM⅐IgG, and the radiolabeled enzymes were released from beads and subjected to SDS-polyacrylamide gel electrophoresis followed by fluorography (24) . Similarly, His⅐ST8Sia IV (BV) secreted from insect cells was used as an enzyme source under the same assay conditions.
RESULTS

ST8Sia IV Synthesized in Insect Cells Polysialylates NCAM but neither Autopolysialylates nor Forms a Homodimer-To
determine the structure and function of ST8SiaIV, ST8Sia IV was produced in insect cells as a soluble protein fused with 6ϫHis peptide. Fig. 2A shows that ST8Sia IV produced in the insect cells, His⅐ST8Sia IV (BV), migrated at the same position regardless of the presence or absence of reducing agent. Its molecular mass (ϳ46 kDa) corresponds to that expected from the amino acid sequence (41 kDa) plus glycosylation, indicating no dimer was formed. To confirm that this is true also for an intact form of ST8Sia IV and ST8Sia II, the entire sequence of ST8SiaIV or ST8Sia II fused with FLAG tag peptide at the COOH terminus was expressed in HeLa cells. It was shown that ST8Sia IV or ST8Sia II fused with the FLAG tag can form polysialic acid in transfected HeLa cells (data not shown). Although a small amount of dimer was also formed in the absence of a reducing agent, ST8Sia IV and ST8Sia II mainly existed as a monomer (Fig. 2B) . The negligible amount of dimers was probably due to nonspecific aggregation, because this amount was increased when the samples were frozen and heated in the sample buffer under milder conditions (data not shown).
As shown in Fig. 3A , ST8Sia IV produced in the insect cells added as much polysialic acid to NCAM as did ST8Sia IV produced in HeLa cells. ST8Sia IV produced in the insect cells, however, failed to add polysialic acid to itself (autopolysialylation) (Fig. 3B) , most likely because ST8Sia IV produced in insect cells contained only immature N-glycans. Indeed, endoneuraminidase treatment did not change the molecular mass of ST8Sia IV produced in the insect cells (data not shown). Moreover, the size of this ST8Sia IV produced in insect cells was smaller than that of the same enzyme produced in HeLa cells ( Fig. 2A) , indicating the difference in N-glycosylation between two cell systems. These results combined demonstrate that ST8Sia IV can extensively form polysialic acid on NCAM when autopolysialylation is not detectable (see also "Discussion").
N-Glycosylation of ST8Sia IV Synthesized in Insect Cells and Mammalian Cells Utilizes the Same Glycosylation Sites-Pre-
viously it has been shown that Asn 74 is the N-glycosylation site where the majority of autopolysialylation occurs (34) . The absence of autopolysialylation could thus occur if Asn 74 is not utilized in the insect cells. To determine whether or not Nglycan was attached to Asn 74 , the ST8SiaIV sample used in the above experiments was subjected to mass spectrometric analysis after tryptic digestion. By liquid chromatography/electron spray ionization-tandem mass spectrometry (LC/ESI-MS/MS) analysis, more than 86% of the amino acid sequence predicted from the ST8Sia IV cDNA was confirmed using the protein data base searching program Sequest. Four of the five peptides that contain N-glycosylation consensus sequences were not detected, but a peptide containing Asn 219 was detected. After treatment with N-glycanase, however, the other peptides containing a consensus N-glycosylation sequence (peptides containing Asn 50 Fig. 4A and its inset mass spectrum) . The MS/MS analysis of the triply charged ion at m/z ϭ 895.8 showed that dominant product ions were generated from N-terminal fragments, y n (n ϭ 8 -10, and 17), and C-terminal fragments b n (n ϭ 11, 13, and 21) (Fig. 4B) . The assignment of MS/MS fragments is based on Biemann's nomenclature (40 Fig. 1 ).
Identification of Free and Disulfide-bonded Cys Residues-As seen in Fig. 1 , ST8Sia IV and other members of the ST8Sia gene family are unique in having a cysteine residue at the COOH terminus, three cysteine residues in sialylmotif L, and one cysteine in sialylmotif S. In contrast, sialyltransferases of other families contain only one conserved cysteine residue in each sialylmotif L and S. These results suggest that the members of the ST8Sia gene family, including ST8Sia IV, may share unique disulfide bond structures. To determine the disulfide bond structures of ST8Sia IV, the enzyme was subjected to mass spectrometric analysis. ST8Sia IV purified from the insect cells was reacted with polyethylene oxide-maleimide biotin
FIG. 2. Absence of disulfide-bonded dimers for ST8Sia II and ST8Sia IV.
A, a soluble form of His⅐ST8Sia IV (HeLa) secreted from HeLa cells and His⅐ST8Sia IV (BV) from insect cells were subjected to SDS polyacrylamide gel electrophoresis before (Ϫ) or after (ϩ) treatment with 2-mercaptoethanol (2-Me). B, full-length ST8Sia II or ST8Sia IV fused with a FLAG peptide was expressed in HeLa cells and then subjected to SDS-polyacrylamide gel electrophoresis before (Ϫ) and after (ϩ) treatment with 2-mercaptoethanol. The separated proteins were blotted to polyvinylidene difluoride membrane and incubated with anti-Xpress (A) or anti-FLAG tag (B) antibody and visualized with ECL kit.
FIG. 3. Incorporation of sialic acid to NCAM and polysialyltransferases themselves by a soluble form of ST8Sia II and ST8Sia IV and CMP-NeuNAc. A, NCAM⅐IgG was incubated with CMP-[
14 C]NeuNAc and His⅐ST8Sia IV (BV) secreted from insect cells or A⅐ST8Sia II and A⅐ST8Sia IV secreted from HeLa cells. A⅐ST8Sia II and A⅐ST8Sia IV were attached to IgG⅐Sepharose whereas His⅐ST8Sia IV (BV) was released from an Ni-column before the assay. B, the same enzyme preparation was incubated with CMP-[ 14 C]NeuNAc without adding an acceptor molecule. The samples were separated by SDS-polyacrylamide gel electrophoresis and subjected to fluorography.
(PEO-maleimide biotin) to label any free Cys residues, denatured, and digested with trypsin or chymotrypsin under nonreducing conditions. The resultant peptides were separated by liquid chromatography and analyzed for peptides containing modified Cys residues by Electrospray Ionization-Tandem Mass Spectrometry (ESI-MS/MS) analysis. A doubly charged ion for the Cys 169 -containing peptide (amino acid residues 166 -177) at m/z ϭ 943.0 was detected. The MS/MS analysis of the ion specie at m/z ϭ 943.0 conclusively demonstrated that Cys 169 was conjugated to the PEO-maleimide biotin with a mass equivalent to that expected for a peptide with a biotinylated Cys residue (data not shown). None of the other Cyscontaining peptides of ST8Sia IV was found to contain a biotinylated Cys residue.
To determine if Cys residues other than Cys 169 participate in disulfide bonds and determine how these residues are linked, chymotryptic digests of non-reduced ST8Sia IV were subjected to LC/ESI-MS/MS analysis. Calculations of all possible disulfide-linked patterns were made, and the data generated from the LC/ESI-MS/MS analysis of a non-reduced chymotryptic digest of ST8Sia IV were searched for possible matches. The search identified a doubly charged ion at m/z ϭ 1082.9 and a triply charged ion at m/z ϭ 722.6, which correspond to the predicted m/z values for a disulfide-linked peptide (Cys 142 -Cys 292 , Fig. 5A ) containing amino acid residues 140 -152 and 292-298. The MS/MS analysis of the doubly charged ion at m/z ϭ 1082.9 produced dominant ions, which were generated from N-terminal fragments, y n (n ϭ 3-5, and 7), from the Cys 292 -containing peptide (amino acid residues 292-298) and COOH-terminal fragments, b n (n ϭ 5, 6, and 7), from the Cys 142 -containing peptide (amino acid residues 140 -152; Fig.  5B ). Each mass of generated peptides was consistent with the calculated mass, confirming the sequence and disulfide structure of Cys 142 -Cys 292 . The search for possible matches also identified a second disulfide-linked peptide (Cys 156 -Cys 356 ) that was detected as both a doubly charged ion at m/z ϭ 1292.5 and a triply charged ion at m/z ϭ 862.4 (Fig. 6A) . The MS/MS spectrum of the doubly charged ion at m/z ϭ 1292.5 showed that the peptide contains disulfide-linked dipeptide containing amino acid residues 153-165 and residues 350 -359 (Fig. 6B) . These to Ala completely inactivated the enzyme when assayed for both NCAM polysialylation and autopolysialylation (Fig. 7) . To exclude the possibility that this inactivation was caused by undesired disulfide pairing, cysteine residues involved in each disulfide bond were mutated together (C142A/C292A and C156A/C356A). The results confirmed the above conclusion that all of the disulfide bond structures are crucial for the enzymatic activity (Fig. 7) . A mutation at Cys 169 also reduced the enzyme activity; however, a small detectable activity for NCAM polysialylation was found for this mutation, whereas autopolysialylation activity was scarcely detected for the same mutant enzyme (Fig. 7) . These results combined together indicate that Cys , and Cys 356 are important for the catalytic activity of ST8Sia IV by forming disulfide bonds whereas Cys 169 is involved in its catalytic activity as a free cysteine.
Roles of COOH-terminal Sequence-The above results demonstrated that Cys
356 close to the COOH-terminal end is critical for the enzymatic activity. To determine if the other amino acid residues in the COOH-terminal sequence are important, the COOH-terminal sequence was either deleted or mutated.
The results demonstrated that removal of three amino acid residues from the CVKQ terminus (IV-3 in Fig. 8 ) had almost no effect on activity (Fig. 9B ), but deletion of Cys 356 (ST8Sia IV-4 in Fig. 8 ) inactivated the enzyme (Fig. 9C ) consistent with the above result. Mutating lysine or glycine or threonine residues adjacent to Cys 356 resulted in only modest decrease in the polysialylation (compare IV-5ϩAC, IV-6ϩAAC, or IV-7ϩAAAC with IV-3 in Figs. 8 and 9F) .
Interestingly, changing the position of Cys 356 to Ϫ1 (IV-5ϩC), Ϫ2 (IV-6ϩC), ϩ1 (IV-4ϩAC), or ϩ2 (IV-4ϩAAC, see Fig.  8 ) resulted in almost complete loss of polysialylation activity (Fig. 9, D and E) . These results indicate that there is a strict requirement for the position of the Cys 356 residue. In all of these mutation experiments (shown in Figs. 7-9) , none of the FIG. 8 . Polysialylation activity of the COOH-terminal mutants of ST8Sia IV. ST8Sia IV was mutated at Cys 356 and flanking sequences as shown, and its activity for NCAM polysialylation was tested by in vitro assay (SF, in vitro) as shown in Fig. 7 . The relative activity derived from an equivalent amount of the enzymes was shown after densitometric analysis of fluorograms. Similar results were obtained when full-length (MF) or soluble (SF) mutated enzymes were expressed in COS-1 cells and immunostained using the 12F8 anti-polysialic acid monoclonal antibody as described in Fig. 9 . Strongly positive and negative activities are denoted by ϩϩϩ and Ϫ, respectively. mutated enzymes showed a detectable misfolding, because all of the soluble mutated enzymes were secreted into the medium in almost equivalent amounts.
The above results suggest the sterical structure formed by the disulfide bond between Cys 356 and Cys 156 is critical, but amino acid residues 357-359 may not be critical for the enzymatic activity. To determine if the addition of a bulky protein to the COOH end renders ST8Sia IV inactive, ST8Sia IV was fused with GFP protein (M r ϳ 27 kDa) at the COOH terminus. HeLa cells transfected with control GFP was negative for polysialic acid (Fig. 9G) . Surprisingly, the addition of GFP to ST8Sia IV did not interfere with the enzymatic activity of ST8Sia IV (Fig. 9H) . Identical results were obtained on ST8Sia II (Fig. 9I) . In contrast to GFP in control cells (Fig. 9G) , the ST8Sia IV⅐GFP or ST8Sia II⅐GFP was stained in perinuclear regions, probably corresponding to the Golgi apparatus. These combined results suggest that the amino acid sequence flanking Cys 356 is not directly involved in catalytic activity but the sterical structure formed by the disulfide bonded Cys 356 -Cys 156 is critical for its activity.
DISCUSSION
In the present study, we demonstrated that ST8Sia IV produced in T. ni insect cells can add polysialic acid to NCAM, although it cannot add polysialic acid to itself (autopolysialylation) (Fig. 3) . Similarly, the C169A mutant enzyme catalyzed NCAM polysialylation but was barely capable of autopolysialylation (Fig. 7) . Previously, it was shown that Nglycans of IgG secreted from T. ni cells lack sialic acid and contain only small amounts of galactosylated N-glycans (41) . The majority of these N-glycans contain N-acetylglucosamineor mannose-terminated N-glycans. We also showed that ST8Sia IV produced in T. ni cells contained an N-glycan attached to Asn 74 , where autopolysialylation preferentially takes place in mammalian cells (34) . These combined results strongly suggest that the lack of autopolysialylation for ST8Sia IV produced in the insect cells is due to a lack of sialylated N-glycans that serve as an acceptor for the enzyme. Previously, Windfuhr et al. (42) reported that autopolysialylation is necessary for NCAM polysialylation, whereas Close et al. (34) reported that autopolysialylation is not necessary for NCAM polysialylation.
Our present study unequivocally demonstrated that ST8Sia IV can add polysialic acid to NCAM in the absence of detectable autopolysialylation.
In the present study, we also determined the disulfide bond structures of ST8Sia IV using improved LC/ESI-MS/MS analysis (37, 38) . Our results demonstrated that the cysteine residue at the COOH-terminal end forms a disulfide bond with the second cysteine residue of sialylmotif L and that the second disulfide bond is formed between the first cysteine at sialylmotif L and the cysteine at sialylmotif S. These disulfide bonds are intramolecularly formed, because almost no homodimer was detected (Fig. 2) . These disulfide bonds thus form a unique structure of ST8Sia IV as depicted in Fig. 10 (middle graphic) . These disulfide bond structures are imperative for the enzymatic activity, because replacement of any of these cysteine residues with alanines resulted in inactivation of the enzyme. This finding is consistent with a recent report on ST8Sia IV derived from mutant Chinese hamster ovary cells, showing that a Cys 356 to Phe 356 mutation inactivated the enzyme (42) . On the other hand, the third cysteine, Cys 169 , in sialylmotif L is present as a free cysteine as shown by mass spectrometric analysis. This cysteine is also involved in the enzymatic activity, because the mutation of this cysteine 169 to alanine reduced the enzymatic activity. This result is consistent with a previous report that at least one free cysteine residue is critical for polysialylation (43) .
In (Figs. 8 and 9 ). These results indicate that disulfide bond formation by Cys 356 is highly constrained in terms of its position, whereas flanking amino acid sequences may not be directly involved in the enzymatic activity. These conclusions can be supported by the fact that the amino acid sequences flanking the conserved cysteine at the COOH terminus are not conserved among five members of the ST8Sia gene family (16 -20, 44 -46) . For example, human ST8Sia III contains only one additional amino acid, alanine after the cysteine residue (45) . These results contrast with the previously obtained results on fucosyltransferase V and N-acetylglucosaminyltransferase V; removal of one and five residues from their COOH terminus abolished the enzymatic activity, although neither enzyme contains a cysteine residue at its COOH terminus (47, 48) . Moreover, the results obtained by site-directed mutagenesis of ST8Sia IV was corroborated by the fact that the addition of GFP protein at the COOH end of ST8Sia IV does not interfere with the enzymatic activity. These results combined suggest that the amino acid sequence flanking Cys 356 may not be directly involved in the catalytic activity of ST8Sia IV, but the sterical structure formed by the disulfide bonds is critical for its activity. The results also provide a useful tool in understanding the roles of ST8Sia IV, because we can determine if the phenotype of those cells expressing ST8Sia IV, detected by GFP produced, differ from those which do not express ST8Sia IV.
Disulfide bond structures found for ST8Sia IV are unique in a way that the amino acid sequence downstream from sialylmotif S to the COOH terminus is in close proximity with sialylmotif L (Fig. 10) . This sterical structure is most likely shared by all members of the ST8Sia gene family, because these four cysteine residues are conserved in these enzymes (see Fig. 1 ). Another member of the ST8Sia gene family, ST8Sia I, has been shown to add continuously one or more ␣2,8-linked sialic acids to glycolipids (44) . The oligosialylated glycolipids are also synthesized by ST8Sia V (46) . ST8Sia III as well as ST8Sia II and IV were shown to polysialylate itself (24) . All ␣2,8-sialyltransferases thus share the ability to add more than one ␣2,8-linked sialic acid to specific acceptor molecules. Such common catalytic activity is observed in only ␣2,8-sialyltransferases, possibly because common disulfide bond structures are shared by this family (see Fig. 10 ). Sialyltransferases of other gene families, ST3Gal I for example (49) , contain only one conserved cysteine in sialylmotif L, which corresponds to the first cysteine in sialylmotif L in ST8Sia IV, and another conserved cysteine in sialylmotif S. If these two cysteine residues are linked to each other as shown in ST8Sia IV, this disulfide bridge would bring sialylmotifs L and S into a close proximity (see Fig. 10 ). This hypothesis is consistent with the findings that both sialylmotifs L and S are involved in binding to CMP-NeuNAc (30, 31) . However, these sialyltransferases lack two additional cysteine residues conserved in the ST8Sia gene family, suggesting that the COOH-terminal region of these sialyltransferases may not be close to sialylmotif L. It is still possible that these sialyltransferases may form a similar structure without a disulfide bond. But such a structure must be different from that constrained by a disulfide bond shown in ST8Sia IV.
In the present study, we found that ST8Sia II and ST8Sia IV form a negligible amount of disulfide-bonded dimer, if any. Previous studies suggest that homodimers and possibly heterodimers of ␤1,4-galactosyltransferase or N-acetylglucosaminyltransferase I may correlate with its Golgi localization (50, 51) . Nillson et al. (52) proposed that the medial Golgi enzymes, ␣-mannosidase II and N-acetylglucosaminyltransferase I, form heterodimers through kin recognition that confers Golgi localization. In all of those studies, the formation of hetero-or homodimers through a disulfide bond was not addressed. Chen et al. (53) , on the other hand, demonstrated that one isoform of ST6Gal I forms disulfide-linked homodimers, which stay in the Golgi. The formation of disulfide-linked homodimers has been also reported for ␣1,2-fucosyltransferase, GM2 synthase, and ␤1,3-glucuronyltransferase (51, 54, 55) . For GM2 synthase, homodimers are formed in anti-parallel orientation, and such a dimeric formation is apparently essential for its activity (54) . In contrast, ␤1,3-glucuronyltransferase that adds the first glucuronic acid in proteoglycan synthesis (55) forms a functional homodimer in parallel orientation through a cysteine in the stem region. Different from these enzymes, it was shown by crystallographic studies that ␤1,4-galactosyltransferase and Nacetylglucosaminyltransferase I do not form homodimers through disulfide bridges and only intramolecular disulfide bridges are formed in these enzymes (56, 57) . Our results indicate that ST8Sia IV belongs to this third group, which does not form homodimers through disulfide bridges. It will be significant to determine if other sialyltransferases belong to any of the above three groups in terms of disulfide bond structures and if such a disulfide bond structure is related to the mode of its catalytic activity. (FN 1 and FN 2 ) of NCAM are shown on the left. It was reported that the fourth and fifth immunoglobulin-like domains and the first fibronectin type III repeat are necessary for recognition by polysialyltransferases (58) . ST8Sia IV, shown in the middle, contains two disulfide bridges, denoted by thin lines with cysteines (circled "c"), and the COOH terminus is close to sialylmotifs L and S. In contrast, sialyltransferases other than those of the ␣2,8-sialyltransferase gene family lack the cysteine at the COOHterminal end, and the COOH terminus is not close to sialylmotif L or sialylmotif S (shown on the right). Sialylmotifs L and S are boxed. q, qⅪ, and Ⅺ denote sialic acid, CMP-NeuNAc and CMP, respectively. N-glycosylation sites in NCAM are shown by the ⌿ symbol.
